Why the study?
Heart disease in SLE is linked to increased morbidity and mortality, yet whether traditional coronary artery disease treatments significantly impact mortality in this population remains unclear.
This review provides a comprehensive overview of the diverse cardiac manifestations of systemic lupus erythematosus and their management.
No takes yet. Share an insight, caveat, or question.
Mortality benefit of standard CAD therapy in SLE remains uncertain; leaves open need for targeted trials.
Linares-Koloffon et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: